Cargando…
Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective
OBJECTIVE: This study aimed to estimate the cost-effectiveness of direct-acting antivirals (DAAs) among patients with non-genotype 1 for the eradication of hepatitis C virus (HCV) infection in China. METHODS: A decision-analytic Markov model was developed to estimate the lifetime costs, quality-adju...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703443/ https://www.ncbi.nlm.nih.gov/pubmed/33246983 http://dx.doi.org/10.1136/bmjgh-2020-003194 |